Avensia AB (publ) (STO:AVEN)

Sage Therapeutics Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	39.16	42.3	15.67	15.41	36.36	41.48
Cash & Short-Term Investments	39.16	42.3	15.67	15.41	36.36	41.48
Cash Growth	112.58%	169.92%	1.69%	-57.61%	-12.34%	17.17%
Accounts Receivable	93.52	82.51	74.21	70.63	85.34	60.53
Other Receivables	-	4.74	10.4	20.44	17.13	17.05
Receivables	93.52	87.25	84.61	91.07	102.46	77.58
Prepaid Expenses	-	8.48	8.43	8.55	9.85	6.2
Other Current Assets	-	2.03	2.31	-	-	-
Total Current Assets	132.67	140.06	111.02	115.03	148.67	125.26
Property, Plant & Equipment	66.91	72.75	76.55	57.18	21.77	28.65
Goodwill	1.75	1.75	1.75	1.75	1.75	1.75
Other Intangible Assets	0.42	0.68	1.82	3.74	5.93	10.27
Long-Term Deferred Tax Assets	1.61	4.55	6.8	4.77	-	0.71
Other Long-Term Assets	0.27	0.32	0.32	0.32	0.28	0.26
Total Assets	203.62	220.1	198.26	182.78	178.41	166.9
Accounts Payable	-	19.59	17.69	23.98	24.72	17.99
Accrued Expenses	-	51.3	45.4	42.62	35.71	40.36
Current Portion of Leases	-	13.84	12.68	11.1	9.53	8.73
Current Income Taxes Payable	-	2.88	1.18	6.85	4.07	0.83
Current Unearned Revenue	-	12.86	9.39	14.83	6.04	5.56
Other Current Liabilities	110.42	19.26	26.06	11.46	20.84	15.41
Total Current Liabilities	110.42	119.73	112.41	110.83	100.91	88.88
Long-Term Debt	-	-	-	-	1.16	1.57
Long-Term Leases	52.63	57.93	59.87	41.01	6.21	13.84
Long-Term Deferred Tax Liabilities	-	-	0.04	0.04	3.12	3.36
Other Long-Term Liabilities	-	-	-0	-	-	-
Total Liabilities	163.91	178.76	173.92	152.35	111.41	107.64
Common Stock	5.57	5.57	5.57	5.57	5.57	5.53
Additional Paid-In Capital	2.43	2.43	2.43	2.43	2.51	3.47
Retained Earnings	31.34	31.8	15.14	21.05	58.47	50.61
Comprehensive Income & Other	0.39	1.55	1.2	1.39	0.46	-0.34
Total Common Equity	39.72	41.34	24.34	30.43	67	59.26
Shareholders' Equity	39.72	41.34	24.34	30.43	67	59.26
Total Liabilities & Equity	203.62	220.1	198.26	182.78	178.41	166.9
Total Debt	52.63	71.77	72.56	52.11	16.91	24.14
Net Cash (Debt)	-13.47	-29.47	-56.88	-36.69	19.46	17.34
Net Cash Growth	-	-	-	-	12.18%	41.59%
Net Cash Per Share	-0.36	-0.79	-1.53	-0.99	0.52	0.47
Filing Date Shares Outstanding	37.12	37.12	37.12	37.12	37.12	36.85
Total Common Shares Outstanding	37.12	37.12	37.12	37.12	37.12	36.85
Working Capital	22.26	20.33	-1.39	4.2	47.76	36.38
Book Value Per Share	1.07	1.11	0.66	0.82	1.80	1.61
Tangible Book Value	37.55	38.91	20.77	24.94	59.31	47.24
Tangible Book Value Per Share	1.01	1.05	0.56	0.67	1.60	1.28
Machinery	-	10.16	11.78	12.98	13.01	11.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.